paroxetine

(redirected from Paroxetine mesylate)
Also found in: Medical, Wikipedia.
Related to Paroxetine mesylate: Paxil

par·ox·e·tine

 (pă-rŏk′sĭ-tēn′)
n.
A drug of the SSRI class, C19H20FNO3, used in its hydrochloride form to treat depression, anxiety, and certain other disorders, including obsessive-compulsive disorder.

[par(a)- + ox(y)- + (m)et(hyl) + (piperid)ine.]

paroxetine

(pæˈrɒksətiːn)
n
(Pharmacology) an antidepressant drug that acts by preventing the re-uptake after release of serotonin in the brain, thereby prolonging its action: used for treating depression, obsessive-compulsive disorders, and panic disorder. Formula: C19H20FNO3
Translations

paroxetine

n paroxetina
Mentioned in ?
References in periodicals archive ?
5 mg of paroxetine mesylate that was specifically developed for the treatment of vasomotor symptoms due to menopause.
The settlement (a) facilitates immediate full-scale marketing of Synthon's FDA-approved PEXEVA(TM) product and (b) further authorizes Synthon to develop and market certain other paroxetine mesylate dosage forms in advance of the expiration of GSK's patents, and is therefore procompetitive.
Food and Drug Administration granted final approval to its Paroxetine Mesylate 10 mg, 20 mg, 30 mg, and 40 mg tablets for the treatment of depression, obsessive/compulsive disorder and/or panic disorder.
Bioequivalent to Paxil, the blockbuster antidepressant from GlaxoSmithKline, which is formulated as paroxetine hydrochloride, Pexeva contains paroxetine mesylate.